• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：接受手术治疗的转移性肺肿瘤患者的临床特征与预后

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors.

作者信息

Zhao Xiaoliang, Wen Xiaohua, Wei Wei, Chen Yulong, Zhu Jianquan, Wang Changli

机构信息

Department of Lung Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer Tianjin, Tianjin, P.R. China.

Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China.

出版信息

Oncotarget. 2019 Jan 4;10(2):252. doi: 10.18632/oncotarget.26575.

DOI:10.18632/oncotarget.26575
PMID:30719218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349433/
Abstract

[This corrects the article DOI: 10.18632/oncotarget.14822.].

摘要

[本文更正了文章的数字对象标识符：10.18632/oncotarget.14822。]

相似文献

1
Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors.更正：接受手术治疗的转移性肺肿瘤患者的临床特征与预后
Oncotarget. 2019 Jan 4;10(2):252. doi: 10.18632/oncotarget.26575.
2
Correction: A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.更正：甲状腺乳头状癌经典型与高细胞变异型的临床病理特征及预后比较：一项荟萃分析
Oncotarget. 2018 Mar 23;9(22):16271. doi: 10.18632/oncotarget.24998.
3
Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.更正：血清癌胚抗原的动力学变化可早期预测转移性非小细胞肺癌患者在贝伐单抗联合培美曲塞维持治疗期间的病情进展。
Oncotarget. 2017 Dec 15;8(66):110732. doi: 10.18632/oncotarget.23291.
4
Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors.接受手术治疗的转移性肺肿瘤患者的临床特征及预后
Oncotarget. 2017 Jul 11;8(28):46491-46497. doi: 10.18632/oncotarget.14822.
5
Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.更正：伊匹单抗对转移性黑色素瘤患者肿瘤来源的扩增T细胞的影响
Oncotarget. 2018 Nov 9;9(88):35870. doi: 10.18632/oncotarget.26359.
6
Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.更正：预测非转移性结直肠癌患者生存的列线图的开发与验证
Oncotarget. 2018 Oct 19;9(82):35373. doi: 10.18632/oncotarget.26274.
7
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma.更正：转移性肾细胞癌治疗的“黄金时代”之路。
Oncotarget. 2018 Nov 6;9(87):35796. doi: 10.18632/oncotarget.26340.
8
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.更正：基因组突变驱动的转移性乳腺癌治疗：单中心经验
Oncotarget. 2017 Sep 22;8(37):62817. doi: 10.18632/oncotarget.20632.
9
Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer.更正：在患有转移性前列腺癌的韩国人群中，溶质载体家族28成员3（SLC28A3）基因变异体rs56350726与去势抵抗性前列腺癌的进展相关。
Oncotarget. 2018 Aug 7;9(61):31938. doi: 10.18632/oncotarget.25970.
10
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11.更正：一项针对携带RAS突变的转移性结直肠癌的一线改良FOLFOXIRI联合贝伐单抗治疗的II期试验：JACCRO CC-11。
Oncotarget. 2018 Jul 6;9(52):30023. doi: 10.18632/oncotarget.25775.